PROCEPT BioRobotics Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
626
- Stock Symbol
-
PRCT
- Share Price
-
$72.66
- (As of Friday Closing)
PROCEPT BioRobotics General Information
Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
Contact Information
Website
www.procept-biorobotics.comCorporate Office
- 900 Island Drive
- Suite 170
- Redwood Shore, CA 94065
- United States
Corporate Office
- 900 Island Drive
- Suite 170
- Redwood Shore, CA 94065
- United States
PROCEPT BioRobotics Timeline
PROCEPT BioRobotics Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $72.66 | $74.31 | $24.83 - $85.81 | $3.77B | 51.9M | 672K | -$2.06 |
PROCEPT BioRobotics Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 2,997,312 | 1,909,049 | 1,685,034 | 821,716 |
| Revenue | 176,575 | 136,191 | 75,014 | 34,473 |
| EBITDA | (105,101) | (105,646) | (81,627) | (50,795) |
| Net Income | (103,709) | (105,897) | (87,154) | (59,853) |
| Total Assets | 374,350 | 404,717 | 309,329 | 337,024 |
| Total Debt | 81,016 | 79,204 | 77,317 | 54,100 |
PROCEPT BioRobotics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PROCEPT BioRobotics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
PROCEPT BioRobotics Comparisons
Industry
Financing
Details
PROCEPT BioRobotics Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Encision | Corporation | Boulder, CO | ||||
| Riverpoint Medical | Private Equity-Backed | Portland, OR | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| CooperSurgical | Corporate Backed or Acquired | Trumbull, CT | ||||
| SeaSpine Holdings | Corporate Backed or Acquired | Carlsbad, CA |
PROCEPT BioRobotics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PROCEPT BioRobotics Patents
PROCEPT BioRobotics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240252271-A1 | Tissue protection systems and methods | Pending | 01-Feb-2023 | ||
| US-20240252226-A1 | Three dimensional imaging and treatment planning | Pending | 01-Feb-2023 | ||
| US-20240252255-A1 | User interface for three dimensional imaging and treatment | Pending | 01-Feb-2023 | ||
| US-20240138808-A1 | Fiducial systems for probe tracking and identification | Pending | 31-Oct-2022 | ||
| US-20230255599-A1 | Apparatus and method to detect tissue stretching during insertion of probes | Pending | 17-Feb-2022 | A61B8/12 |
PROCEPT BioRobotics Executive Team (15)
| Name | Title | Board Seat |
|---|---|---|
| Reza Zadno Ph.D | Chief Executive Officer & Board Member | |
| Kevin Waters | Chief Financial Officer, Finance & Executive Vice President | |
| Hisham Shiblaq | Chief Commercial Officer | |
| Alaleh Nouri JD | Executive Vice President & Secretary, Administration | |
| Barry Templin | Senior Vice President, Clinical and Medical Affairs |
PROCEPT BioRobotics Board Members (17)
| Name | Representing | Role | Since |
|---|---|---|---|
| Amy Dodrill | Self | Board Member | |
| Antal Desai | CPMG | Board Member | |
| Elisabeth Sandoval-Little | Self | Board Member | |
| Frederic Moll MD | Self | Board Member | |
| Larry Wood | Self | Board Member |
PROCEPT BioRobotics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PROCEPT BioRobotics ESG
Risk Overview
Risk Rating
Updated September, 04, 2023
28.64 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Healthcare
Industry
of 634
Rank
Percentile
Medical Devices
Subindustry
of 225
Rank
Percentile
PROCEPT BioRobotics FAQs
-
When was PROCEPT BioRobotics founded?
PROCEPT BioRobotics was founded in 2009.
-
Who is the founder of PROCEPT BioRobotics?
Nikolai Aljuri Ph.D and Rodney Perkins MD are the founders of PROCEPT BioRobotics.
-
Who is the CEO of PROCEPT BioRobotics?
Reza Zadno Ph.D is the CEO of PROCEPT BioRobotics.
-
Where is PROCEPT BioRobotics headquartered?
PROCEPT BioRobotics is headquartered in Redwood Shore, CA.
-
What is the size of PROCEPT BioRobotics?
PROCEPT BioRobotics has 626 total employees.
-
What industry is PROCEPT BioRobotics in?
PROCEPT BioRobotics’s primary industry is Surgical Devices.
-
Is PROCEPT BioRobotics a private or public company?
PROCEPT BioRobotics is a Public company.
-
What is PROCEPT BioRobotics’s stock symbol?
The ticker symbol for PROCEPT BioRobotics is PRCT.
-
What is the current stock price of PROCEPT BioRobotics?
As of 04-Oct-2024 the stock price of PROCEPT BioRobotics is $72.66.
-
What is the current market cap of PROCEPT BioRobotics?
The current market capitalization of PROCEPT BioRobotics is $3.77B.
-
What is PROCEPT BioRobotics’s current revenue?
The trailing twelve month revenue for PROCEPT BioRobotics is $177M.
-
Who are PROCEPT BioRobotics’s competitors?
Encision, Riverpoint Medical, Spine Wave, CooperSurgical, and SeaSpine Holdings are some of the 9 competitors of PROCEPT BioRobotics.
-
What is PROCEPT BioRobotics’s annual earnings per share (EPS)?
PROCEPT BioRobotics’s EPS for 12 months was -$2.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
